CFAR Supplement Fiscal Year 2018

The UNC CFAR will conduct an internal review to select the four best candidates for Fiscal Year 2018 funding to move forward with the supplement application.

All interested applicants must submit for review the following:

Documents for internal CFAR review:

Brief proposal no more than 2 pages with specific aims and brief background.

Must have: One paragraph on how this supplement will be used as leverage for RO1 funding: the more specific the better.

Date of submission: Monday, April 2nd by 5:00 P.M.

Send submission to: Dr. Prema Menezes

Details about FY18 supplement opportunity for eligible CFARs:

The CFAR program would like to announce an FY18 supplement opportunity for eligible CFARs.  This year we have six scientific areas of interest.  Eligible CFARs may submit more than one application in any area BUT no more than four total applications per CFAR.  The Developmental Cores should review applications for feasibility and appropriateness of budget in addition to scientific merit as described in the attached announcement.

The NIH is interested in supplement applications from CFARs in the following scientific areas:

  • Basic Research on HIV Infection and Persistence
  • Infant Immunity for HIV Vaccine Development
  • Studies to Delineate Sex Differences in the Incidence of Heart, Lung, Blood, and Sleep Comorbidities in People Living with HIV
  • Formative Research on Behavioral Aspects of Novel Biomedical HIV Prevention and Treatment Regimens
  • The Evolving Opioid Epidemic and its HIV Consequences
  • Implementation of Evidence-Based HIV Interventions and Treatments for Health Disparity Populations

Please see the attached CFAR supplement announcement for more details on the above scientific areas of interest and NIH scientific contacts.   CFARs are encouraged but not required to support investigators who have not previously received a CFAR supplement.

The key aspects of this funding opportunity are:

  • Applications may be submitted for up to one year with maximum funding per application of up to $150,000 Direct Costs
  • Four total applications are permitted per CFAR
  • Project directors must be early career investigators who have never received an R-series research grant in HIV/AIDS or established investigators in non-HIV fields
  • Each CFAR should have an internal review process to submit the most competitive applications
  • CFARs with a high unobligated balance may be disapproved for supplemental funding – please include additional information per the announcement
  • CFARs in the first year of a competing renewal must contact program regarding additional requirements
  • CFARs in the last year of a competitive segment or in a bridge period are not eligible to apply but could collaborate with another CFAR
  • The deadline for applications to be received at NIAID is May 14, 2018
  • The earliest anticipated start date is 6/29/18 but may be delayed due to administrative issues

Please note that the number of applications that will be funded for this administrative supplement announcement will be based on funding availability, scientific merit, and program balance.  Applications must align with the NIH HIV/AIDS research priorities (NOT-OD-15-137).

Updated NIAID CFAR Website

Screen Shot 2016-09-16 at 1.50.31 PM

The National Institute of Allergy and Infectious Diseases has launched a new CFAR website!

Click here to learn more about The Centers for AIDS Research (CFAR) program at the National Institutes of Health, which provides administrative and shared research support to synergistically enhance and coordinate high quality AIDS research projects. More updates and a project map are forthcoming in October updates on the website!

The CFAR program emphasizes the importance of interdisciplinary collaboration, especially between basic and clinical investigators as well as behavioral scientists to support translational research. The CFAR program also encourages training and mentoring of young investigators as well as an inclusion of women and minorities.

UNC bioethicist addresses lack of HIV studies in pregnant women

UNC School of Medicine’s Anne Lyerly is addressing the urgent need for effective HIV prevention and treatment for the estimated 1.5 million women worldwide with HIV who give birth each year. With a $3 million NIH grant, Dr. Lyerly is leading an interdisciplinary team of researchers to determine what barriers prevent investigators from studying the virus in pregnant women.

Lyerly, associate director of the UNC Center for Bioethics and associate professor of social medicine at the UNC School of Medicine, is also an obstetrician/gynecologist who studies ethically complex clinical and policy issues related to women’s reproductive health.

In the August issue of the Journal of the International AIDS Society, Lyerly addresses the lack of research of HIV-positive pregnant women and pregnant women who are at risk of contracting HIV, which has “led to a dearth of evidence to guide safe and effective treatment and prevention of HIV in pregnancy,” Lyerly wrote.

In the research on the HIV-positive pregnant women that has been done, most outcomes focus entirely on the health of the fetus. Pregnant women are excluded from the vast majority of studies, including studies on how to best prevent HIV.

Read more here…

Strategies for an HIV Cure 2014 Conference

Cure“Strategies for an HIV Cure 2014” Conference

Wednesday, October 15- Friday, October 17, 2014, NIH Campus, Bethesda, MA

Registration deadline: Monday, September 29

For more information, visit:

The Division of AIDS (DAIDS) at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is sponsoring a scientific meeting focused on the development of innovative strategies to cure HIV infection. The meeting will cover a comprehensive range of topics spanning basic and translational research, drug discovery and development, and clinical research.